1. Long-term function of cryopreserved aortic homografts. A ten-year study
- Author
-
J K, Kirklin, D, Smith, W, Novick, D C, Naftel, J W, Kirklin, A D, Pacifico, N C, Nanda, F R, Helmcke, and R C, Bourge
- Subjects
Adult ,Aged, 80 and over ,Cryopreservation ,Male ,Reoperation ,Adolescent ,Graft Survival ,Heart Valve Diseases ,Infant ,Middle Aged ,Survival Analysis ,Aortic Aneurysm ,Aortic Dissection ,Actuarial Analysis ,Echocardiography ,Aortic Valve ,Child, Preschool ,Humans ,Transplantation, Homologous ,Female ,Child ,Aged ,Follow-Up Studies - Abstract
Cryopreserved aortic valve homografts have become an accepted aortic valve substitute, but long-term studies with echocardiographic assessment of valve function are largely unavailable. Between 1981 and January 1, 1991, a total of 178 patients aged 9 months to 80 years (median 46 years) underwent implantation of a cryopreserved aortic valve homograft. Serial two-dimensional Doppler echocardiographic studies were obtained in 149 patients. Overall survival was 91% at 1 year and 85% at 8 years. Survival of patients undergoing isolated primary infracoronary aortic valve replacement was 99% at 1 month and 94% at 8 years. Twelve patients underwent homograft explanation. Freedom from explantation for leaflet degeneration was 95% at 8 years. Freedom from presumed leaflet failure (valve degeneration at explantation or aortic insufficiency grade 3/4 or more without reoperation on echocardiography) was 94% at 5 years and 85% at 8 years. By multivariable analysis younger recipient age was the only risk factor identified for leaflet failure. Ninety-five percent of patients followed up for 4 or more years were in New York Heart Association class I or II.
- Published
- 1993